Tag: bipolar disorder; neuroimaging; biomarker; lithium; SSRI; Lithium pharmacodynamics

Isolating the Norepinephrine Pathway Comparing Lithium in Bipolar Patients to Ssris in Depressive Patients

Introduction: The purpose of this investigatory neuroimaging analysis was done to better understand the pharmacodynamics of Lithium by isolating the norepinephrine pathway in the brain. To accomplish this, we compared patients with Bipolar Disorder treated with Lithium to patients diagnosed with Major Depression or Depressive Disorder who are treated with Selective Serotonin Reuptake Inhibitors